Literature DB >> 36212252

CONGENITAL ADRENAL HYPERPLASIA WITH COMPOUND HETEROZYGOUS I2 SPLICE AND P453S MUTATIONS.

B Almacan1, N Ozdemir1, H Onay2, Z Hekimsoy1.   

Abstract

Background: Congenital adrenal hyperplasia (CAH) is an autosomal recessive inherited disorder caused by congenital deficiency of enzymes involved in cortisol biosynthesis from cholesterol in the adrenal cortex. In this article, we aimed to present a 29-year-old female patient with I2 splice point mutation detected in one allele and P453S mutation on the other allele of CYP21A2 gene associated with 21-hydroxylase deficiency. Her further investigation revealed that her mother had P453S mutation and her father had I2 splice mutation. Case report: A 29-year-old woman with CAH was admitted to our clinic with the request of pregnancy. Her physical examination revealed a height of 151 cm, weight 59 kg, body mass index 25.8 kg/m2. According to Tanner staging, she had Stage 3 breast development and pubic hair. Her laboratory test results were as follows: Glucose: 79 mg/dL (70-100 mg/dL), Creatinine: 0.6 (0.5-0.95 mg/dL), Sodium: 138 mEq/L (135-145 mEq/L), Potassium: 4.4 mEq/L (3.5-5.1 mEq/L), Cortisol: 0.05 µg/dL, ACTH: <5.00 pg/mL (5-46 pg/mL), 17-OH progesterone: 7.67 ng/mL (0-3 ng/mL). Chromosome analysis revealed a 46, XX karyotype. CYP21A2 gene mutation analysis was performed for the patient whose clinical history and laboratory results were compatible with congenital adrenal hyperplasia. During the reverse dot blot analysis, I2 splice mutation in one allele and P453S mutation in the other allele were detected.
Conclusion: Although the I2 splice mutation detected in our case was mostly associated with a salt-wasting form of CAH, it was thought that the other P453S mutation detected may explain the relatively good clinical course in our case. ©2022 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Congenital adrenal hyperplasia; I2 splice mutation; P453S mutation

Year:  2022        PMID: 36212252      PMCID: PMC9512366          DOI: 10.4183/aeb.2022.228

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  14 in total

1.  Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency.

Authors:  T A Bachega; A E Billerbeck; G Madureira; J A Marcondes; C A Longui; M V Leite; I J Arnhold; B B Mendonca
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

2.  Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.

Authors:  Roxana Marino; Pablo Ramirez; Jesica Galeano; Natalia Perez Garrido; Carlos Rocco; Marta Ciaccio; Diana M Warman; Gabriela Guercio; Eduardo Chaler; Mercedes Maceiras; Ignacio Bergadá; Mirta Gryngarten; Viviana Balbi; Esther Pardes; Marco A Rivarola; Alicia Belgorosky
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

3.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

4.  Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China.

Authors:  Ling Su; Xi Yin; Jing Cheng; Yanna Cai; Dongyan Wu; Zhichun Feng; Li Liu
Journal:  Clin Chim Acta       Date:  2018-07-24       Impact factor: 3.786

5.  Clinical, biochemical and genetic features with nonclassical 21-hydroxylase deficiency and final height.

Authors:  Şenay Savaş-Erdeve; Semra Çetinkaya; Zehra Yavaş Abalı; Şükran Poyrazoğlu; Firdevs Baş; Merih Berberoğlu; Zeynep Sıklar; Özlem Korkmaz; Derya Buluş; Emine Demet Akbaş; Tülay Güran; Ece Böber; Onur Akın; Gülay Can Yılmaz; Zehra Aycan
Journal:  J Pediatr Endocrinol Metab       Date:  2017-07-26       Impact factor: 1.634

Review 6.  21-hydroxylase deficiency congenital adrenal hyperplasia.

Authors:  M I New
Journal:  J Steroid Biochem Mol Biol       Date:  1994-01       Impact factor: 4.292

7.  Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.

Authors:  Katja K Dumic; Zorana Grubic; Tony Yuen; Robert C Wilson; Vesna Kusec; Ingeborg Barisic; Katarina Stingl; Ivona Sansovic; Veselin Skrabic; Miroslav Dumic; Maria I New
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-31       Impact factor: 4.292

Review 8.  Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Alan A Parsa; Maria I New
Journal:  J Steroid Biochem Mol Biol       Date:  2016-07-02       Impact factor: 4.292

9.  Ethnic disparity in 21-hydroxylase gene mutations identified in Pakistani congenital adrenal hyperplasia patients.

Authors:  Aysha H Khan; Muniba Aban; Jamal Raza; Naeem Ul Haq; Abdul Jabbar; Tariq Moatter
Journal:  BMC Endocr Disord       Date:  2011-02-18       Impact factor: 2.763

10.  Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients.

Authors:  Stefan Riedl; Friedrich-Wilhelm Röhl; Walter Bonfig; Jürgen Brämswig; Annette Richter-Unruh; Susanne Fricke-Otto; Markus Bettendorf; Felix Riepe; Gernot Kriegshäuser; Eckhard Schönau; Gertrud Even; Berthold Hauffa; Helmuth-Günther Dörr; Reinhard W Holl; Klaus Mohnike
Journal:  Endocr Connect       Date:  2019-02-01       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.